Tennessee 2025-2026 Regular Session

Tennessee Senate Bill SB0522 Latest Draft

Bill / Chaptered Version Filed 04/04/2025

                            ..... 
: RICi~RE 
1
.HJ: 
: . ,.' ( )it;J; 
~-..::~~-: -
~tate of \!tennessee 
PUBLIC CHAPTER NO. 145 
HOUSE BILL NO. 502 
By Representatives Littleton, McCalmon, Helton-Haynes, Rudder, Carringer, Hill, 
Alexander, Bricken, Cepicky, Eldridge, Hardaway, Love 
Substituted for: Senate Bill No. 522 
By Senator Roberts 
AN ACT to amend Tennessee Code Annotated, Title 56 and Title 71, relative to 
TennCare. 
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE: 
SECTION 1. Tennessee Code Annotated, Title 71, Chapter 5, Part 1, is amended by 
adding the following as a new section: 
(a) As used in this section: 
(1) "Bureau" means the bureau of TennCare; 
(2) "Enrollee" means an individual enrolled in TennCare; 
(3) "Kleefstra syndrome" means a rare genetic disorder resulting from a 
mutation in the euchromatic histone methyltransferase 1 (EHMT1) gene or a 
deletion of a region of chromosome 9 that includes the EHMT1 gene that affects 
multiple organs and functions of the body, including the face, brain, heart, and 
kidneys, and that is characterized by features, including, but not limited to: 
(A) Developmental delay; 
(8) Intellectual disability; 
(C) Distinctive facial features; 
(D) Speech and hearing disorders; 
(E) Seizures; 
(F) Gastrointestinal disorders; 
(G) Respiratory infections; 
(H) Autism; 
(I) Obesity; and 
(J) Organ defects. 
(b) The bureau may provide coverage and benefits on behalf of an enrollee for 
the diagnosis, including genetic testing, and treatment of Kleefstra syndrome in the 
same manner and to the same extent that the bureau provides coverage for autism 
spectrum disorder, Trisomy 21 or Down syndrome, and other similar or related genetic 
disorders, when determined to be medically necessary pursuant to§ 71-5-144. 
(c) Coverage and benefits under subsection (b) may include early intervention 
and promoting improvements to the enrollee's quality of life and development throughout 
the life of the enrollee through: 
(1) Appropriate modalities of therapy;  HB502 
(2) Appropriate medications; and 
(3) Other interventive programs, education, treatments, clothing, devices, 
and equipment. 
(d) The director of TennCare may apply for a federal waiver as the director 
deems necessary to effectuate this section. 
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it. 
2  HOUSE BILL NO. 502 
PASSED: March 20. 2025 
CAMERO~XTON,SPEAKER 
HOUSE OF REPRESENTATIVES 
RANDY NlCNALL Y 
SPEAKER OF THEIENATE 
APPROVED this --2i.._ day of !\pr; I 2025 
~VA 
BILL LEE, GOVERNOR